Education
About Us
Working with TipRanks
Follow Us
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
RESEARCH TOOLSreports
Total Valuation
OKYO Pharma Limited Sponsored ADR has a market cap or net worth of $112.65M. The enterprise value is $1.86B.
Market Cap$112.65M
Enterprise Value$1.86B
Share Statistics
OKYO Pharma Limited Sponsored ADR has 37,424,294 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,424,294
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OKYO Pharma Limited Sponsored ADR’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.27%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)0.27%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee0.00
Profits Per Employee-5.61M
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OKYO Pharma Limited Sponsored ADR is -2.56K. OKYO Pharma Limited Sponsored ADR’s PEG ratio is 4.36.
PE Ratio-2.56K
PS Ratio0.00
PB Ratio5.58K
Price to Fair Value-7.34
Price to FCF-934.25
Price to Operating Cash Flow-934.87
PEG Ratio4.36
Income Statement
In the last 12 months, OKYO Pharma Limited Sponsored ADR had revenue of 0.00 and earned ― in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit―
Operating Income―
Pretax Income-16.80M
Net Income―
EBITDA―
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures 0.00, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share0.00
Dividends & Yields
OKYO Pharma Limited Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change100.00%
50-Day Moving Average1.60
200-Day Moving Average1.24
Relative Strength Index (RSI)65.63
Average Volume (3m)212.79K
Important Dates
OKYO Pharma Limited Sponsored ADR upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateNov 29, 2024
Next Earnings DateAug 5, 2025
Ex-Dividend Date―
Financial Position
OKYO Pharma Limited Sponsored ADR as a current ratio of 0.21, with Debt / Equity ratio of 0.00%
Current Ratio0.21
Quick Ratio0.21
Debt to Market Cap0.00
Net Debt to EBITDA52.51
Interest Coverage Ratio0.00
Taxes
In the past 12 months, OKYO Pharma Limited Sponsored ADR has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate>-0.01
Enterprise Valuation
OKYO Pharma Limited Sponsored ADR EV to EBITDA ratio is -2.69K, with an EV/FCF ratio of -4.46.
EV to Sales0.00
EV to EBITDA-2.69K
EV to Free Cash Flow-4.46
EV to Operating Cash Flow-4.46
Balance Sheet
OKYO Pharma Limited Sponsored ADR has $987.20K in cash and marketable securities with $1.81K in debt, giving a net cash position of -$985.39K billion.
Cash & Marketable Securities$987.20K
Total Debt$1.81K
Net Cash-$985.39K
Net Cash Per Share-$0.03
Tangible Book Value Per Share-$0.20
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for OKYO Pharma Limited Sponsored ADR is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.00
Price Target Upside173.44% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―